Center for Health Market Innovations (CHMI)

Programs

TB CARE I

last updated Aug 15, 2012

Overview

Implementing organization: 
Management Sciences for Health (MSH)
Implementation Partner(s): 
KNCV Tuberculosis Foundation;American Thoracic Society (ATS), FHI 360, International Union Against Tuberculosis and Lung Disease (The Union), Japan Anti-Tuberculosis Association (JATA), and the World Health Organization (WHO).
Year Launched: 
2010-2015
Stage: 
Existing/expansion stage
Income Level of Target Population: 
All income levels

Funding

Primary Source of Funding: 
Donor
Additional Source(s) of Funding: 
Government
Funders: 
USAID; Global Fund
Summary: 

TB CARE I is a follow-on program to the Tuberculosis Control Assistance Program (TB CAP) and aims to decrease morbidity and mortality by increasing case detection and treatment success of pulmonary TB patients in USAID priority countries. The project collaborates with other national and international initiatives in providing global leadership and support to National TB control efforts.

Program goals/rationale: 

TB CARE I contribute to three USAID target areas:

  1. Sustain or exceed 84% case detection rate and 87% treatment success rate

  2. Treat successfully 2.55 million new sputum-positive TB cases

  3. Diagnose and treat 57,200 new cases of MDR-TB

Key program components: 

TB CARE I will focuses on eight priority Technical Areas, namely: Universal and Early Access; Laboratories; Infection Control (IC); Programmatic Management of Drug Resistant TB (PMDT); TB/HIV; Health Systems Strengthening; Monitoring & Evaluation (M&E), Operations Research (OR) and Surveillance; and Drug Supply and Management.

There are also four over-arching elements:

  1. Collaboration and Coordination
  2. Access to TB services for all people
  3. Responsible and Responsive Management Practices
  4. Evidence-based Monitoring and Evaluation.

Within TB CARE I, Management Sciences of Health, the implementing organization, makes unique contributions to strengthening and expanding DOTS programs; improving the capacity and quality of laboratory networks; strengthening TB and HIV/AIDS collaboration; increasing TB data quality and use; and ensuring the sustainable supply of TB drugs. MSH is making significant contributions as a coordinating partner in Afghanistan, Ghana, South Sudan, and several core projects. MSH also plays a key collaborating role in Cambodia, Ethiopia, Indonesia, Kenya, Mozambique, Nigeria, Vietnam, Zambia and other core projects.

Hide this

Need help?

Using the CHMI Programs Database

  • Browse: Browse the database by applying one or more filters to narrow your search by characteristics. Click the "x" to remove any of the filters you've selected. Click "reset search" to remove all filters and start over.
  • Search: Search the database for a specific program by typing a name or keyword into the search box.
  • Add: If the program you're looking for is not in the CHMI database, submit the program to the CHMI pipeline by clicking here to add a program profile.
  • Update: If you notice incorrect or outdated information, or would like to help complete a profile for a CHMI pipeline program, request a change by clicking here, or at the top of the program profile.

Have a question? Check the FAQs first. Don’t see your question? Contact us.